VKTX241101C50000
- 25.55
- +2.45+10.61%
Viking Therapeutics Newsroom
Form 144 | Viking Therapeutics(VKTX.US) Officer Proposes to Sell 10.28 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 28, $Viking Therapeutics(VKTX.US)$ Officer GREG ZANTE intends to sell 131.69K shares of its common stock on Oct 28, with a total market value of approximately $10.28
Express News | Viking Therapeutics to Highlight Clinical Data From Vk2735 Obesity Program in Presentations at Obesityweek® 2024
Viking Therapeutics to Highlight Clinical Data From VK2735 Obesity Program in Presentations at ObesityWeek 2024
Oppenheimer's One Buy Vs. One Sell Idea From Each SMID Sector
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Viking Therapeutics Insider Sold Shares Worth $1,272,000, According to a Recent SEC Filing
Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $120
Viking Therapeutics Options Spot-On: On October 25th, 90,685 Contracts Were Traded, With 218.76K Open Interest
On October 25th ET, $Viking Therapeutics(VKTX.US)$ had active options trading, with a total trading volume of 90,685 options for the day, of which put options accounted for 20.49% of the total
A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $95 to $125
"Weight loss drug newcomer" Viking (VKTX.US) Q3 performance exceeds expectations, VK2735 prospects are unanimously bullish on Wall Street.
viking therapeutics surged on Thursday, as Wall Street has high hopes for its obesity candidate drug VK2735 latest developments, and the company also announced better-than-expected financial data for the third quarter.
Viking Therapeutics Options Spot-On: On October 24th, 105.23K Contracts Were Traded, With 200.08K Open Interest
On October 24th ET, $Viking Therapeutics(VKTX.US)$ had active options trading, with a total trading volume of 105.23K options for the day, of which put options accounted for 23.65% of the total
Sector Update: Health Care Stocks Decline Thursday Afternoon
3 Health Care Stocks Moving In Thursday's Intraday Session
Q3 2024 Viking Therapeutics Inc Earnings Call
Viking Therapeutics' Stock Soars 18% as Data on Oral Weight-loss Drug Looms
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $90 to $138
Health and Wellness Industry Embraces Surge in Demand for Weight Loss Drugs
Express News | Viking Therapeutics Inc : Raymond James Raises Target Price to $122 From $118
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)